Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10.04.EVERSANA adds AI to medical, legal and regulatory reviews
10.04.Sun Pharma overturns block on alopecia drug launch in US
10.04.At-home tablet now an option for NHS bladder cancer patients
10.04.US government appeals after judge blocks NIH funding cap
10.04.Cheaper Soliris biosimilars reach the US market
09.04.Jazz pays $145m to resolve Xyrem antitrust disputes
09.04.BMS bags a double-quick colorectal cancer approval from FDA
09.04.CRUK scientists find new tool to test lung cancer therapies
09.04.Report says US biotech needs $15bn support to fend off China
09.04.Pharma warns EU of "exodus to US" without reform
08.04.FDA nod broadens use of Brainomix's stroke AI
08.04.Rinvoq cleared for giant cell arteritis in EU, ahead of US
08.04.AZ, Daiichi get EU okay for breast cancer drug Datroway
08.04.UK unveils £600m investment in health data research
08.04.EU due to meet with pharma today to discuss tariffs
07.04.GSK makes fresh neuroscience foray with £2bn+ ABL deal
07.04.Epsilogen buys rival cancer antibody firm TigaTx
07.04.Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug
07.04.Trump blocks plan for Medicare to cover weight-loss drugs
07.04.Measles claims another life in US - and RFK Jr lauds vaccine
04.04.Paige's cancer detection AI gets FDA breakthrough status
04.04.MoonLake secures $500m for lead drug, plus other financings
04.04.Lilly throws lifeline to Sangamo with $1.4bn licensing deal
04.04.AZ grabs pair of EU approvals for top cancer drugs
04.04.Uplizna is first drug FDA-cleared for rare disease IgG4-RD